These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 7807562

  • 41. Long-term home studies of water balance in patients with nocturnal enuresis.
    Rittig S, Schaumburg H, Schmidt F, Hunsballe JM, Hansen AF, Kirk J, Vestergaard P, Djurhuus JC.
    Scand J Urol Nephrol Suppl; 1997; 183():25-6; discussion 26-7. PubMed ID: 9165600
    [Abstract] [Full Text] [Related]

  • 42. Clinical efficacy and safety of desmopressin in the treatment of nocturnal enuresis.
    Klauber GT.
    J Pediatr; 1989 Apr; 114(4 Pt 2):719-22. PubMed ID: 2647954
    [No Abstract] [Full Text] [Related]

  • 43. [New therapeutic prospect in enuresis: desmopressin (DDAVP)].
    Segni G, Salvaggio E, Parenti D, Cataldi L, Auriti C, Rossodivita A, Fano M.
    Minerva Pediatr; 1982 Jan 31; 34(1-2):45-52. PubMed ID: 7040932
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Desmopressin in the management of nocturnal enuresis in children: a double-blind study.
    Birkásová M, Birkás O, Flynn MJ, Cort JH.
    Pediatrics; 1978 Dec 31; 62(6):970-4. PubMed ID: 366538
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Hyponatremia in children treated with desmopressin.
    Robson WL, Leung AK.
    Arch Pediatr Adolesc Med; 1998 Sep 31; 152(9):930-1. PubMed ID: 9743047
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Dangers of intranasal desmopressin for nocturnal enuresis.
    Bamford MF, Cruickshank G.
    J R Coll Gen Pract; 1989 Aug 31; 39(325):345-6. PubMed ID: 2556566
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Morbidity and mortality associated with vasopressin analogue treatment.
    Toumba M, Stanhope R.
    J Pediatr Endocrinol Metab; 2006 Mar 31; 19(3):197-201. PubMed ID: 16607917
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. The efficacy and safety of oral desmopressin in children with primary nocturnal enuresis.
    Schulman SL, Stokes A, Salzman PM.
    J Urol; 2001 Dec 31; 166(6):2427-31. PubMed ID: 11696804
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. DDAVP-associated hyponatremia.
    Delfanian K, Zawada ET.
    S D J Med; 2001 Jul 31; 54(7):255-6. PubMed ID: 11471328
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. The role of bladder capacity in antidiuretic and anticholinergic treatment for nocturnal enuresis.
    Radvanska E, Kovács L, Rittig S.
    J Urol; 2006 Aug 31; 176(2):764-8; discussion 768-9. PubMed ID: 16813940
    [Abstract] [Full Text] [Related]

  • 58. Nocturnal enuresis.
    Davis RC, Morris DS, Briggs JE.
    Lancet; 2006 Aug 31; 340(8834-8835):1550. PubMed ID: 1361639
    [No Abstract] [Full Text] [Related]

  • 59. Clinical inquiries. How effective is desmopressin for primary nocturnal enuresis?
    Diehr S, Scoville C, Bercaw DM.
    J Fam Pract; 2003 Jul 31; 52(7):568-9. PubMed ID: 12841976
    [No Abstract] [Full Text] [Related]

  • 60. [The use of DDAVP (desmopressin) in primary nocturnal enuresis].
    Bernasconi S, Monti G.
    Minerva Pediatr; 1982 Feb 15; 34(3):131-4. PubMed ID: 7078535
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.